Key Information for Walgreens Boots Alliance (WBA) Investors Today

Walgreens Boots Alliance logged a 2.8% change during today's afternoon session, and is now trading at a price of $22.5 per share. On average, analysts give it a target price of $29.89.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. The large-cap company is based in the United States. Walgreens Boots Alliance currently returns an annual dividend yield of 8.8%.

Make Sure to Consider the Following Before Buying Walgreens Boots Alliance:

  • Walgreens Boots Alliance has moved -33.0% over the last year.

  • WBA has a forward P/E ratio of 6.3 based on its EPS guidance of 3.55.

  • Over the last 6 years, earnings per share (EPS) have been growing at a compounded average rate of -16.7%.

  • The company has a price to earnings growth (PEG) ratio of -2.96.

  • Its Price to Book (P/B) ratio is 0.92

Walgreens Boots Alliance Has a Deteriorating Pattern of Cash Flows

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2022-10-13 3,899,000 -400,000 4,299,000 -33.67
2021-10-14 5,555,000 -926,000 6,481,000 -4.24
2020-10-15 5,484,000 -1,284,000 6,768,000 -5.73
2019-10-28 5,594,000 -1,585,000 7,179,000 -20.02
2018-10-11 8,264,000 -712,000 8,976,000 5.07
2017-10-25 7,251,000 -1,292,000 8,543,000

Walgreens Boots Alliance's free cash flows may average out to $7.04 Billion over the last 6 years, but its persistently negative year-on-year growth could be a red flag. Indeed, its free cash flow CAGR is 0.0% and its coefficient of variability is 17090525454.4%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.